Roses DF - Search Results

1

Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.

Mosoyan G, Nagi C, Marukian S, Teixeira A, Simonian A, Resnick-Silverman L, DiFeo A, Johnston D, Reynolds SR, Roses DF, Mosoian A. Mosoyan G, et al. Among authors: roses df. PLoS One. 2013;8(1):e55145. doi: 10.1371/journal.pone.0055145. Epub 2013 Jan 25. PLoS One. 2013. PMID: 23372829 Free PMC article.

2

Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma.

Reynolds SR, Zeleniuch-Jacquotte A, Shapiro RL, Roses DF, Harris MN, Johnston D, Bystryn JC. Reynolds SR, et al. Among authors: roses df. Clin Cancer Res. 2003 Feb;9(2):657-62. Clin Cancer Res. 2003. PMID: 12576432

3

A genomic ruler to assess oncogenic transition between breast tumor and stroma.

Dhage S, Ernlund A, Ruggles K, Axelrod D, Berman R, Roses D, Schneider RJ. Dhage S, et al. PLoS One. 2018 Oct 16;13(10):e0205602. doi: 10.1371/journal.pone.0205602. eCollection 2018. PLoS One. 2018. PMID: 30325954 Free PMC article.

4

Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma.

Reynolds SR, Albrecht J, Shapiro RL, Roses DF, Harris MN, Conrad A, Zeleniuch-Jacquotte A, Bystryn JC. Reynolds SR, et al. Among authors: roses df. Clin Cancer Res. 2003 Apr;9(4):1497-502. Clin Cancer Res. 2003. PMID: 12684425

5

Decrease in circulating tumor cells as an early marker of therapy effectiveness.

Bystryn JC, Albrecht J, Reynolds SR, Rivas MC, Oratz R, Shapiro RL, Roses DF, Harris MN, Conrad A. Bystryn JC, et al. Among authors: roses df. Recent Results Cancer Res. 2001;158:204-7. doi: 10.1007/978-3-642-59537-0_21. Recent Results Cancer Res. 2001. PMID: 11092048

6

Morphological and biological characteristics of mammogram-detected invasive breast cancer.

Moezzi M, Melamed J, Vamvakas E, Inghirami G, Mitnick J, Quish A, Bose S, Zelman G, Roses D, Harris M, Feiner H. Moezzi M, et al. Hum Pathol. 1996 Sep;27(9):944-8. doi: 10.1016/s0046-8177(96)90222-1. Hum Pathol. 1996. PMID: 8816890 Free article.

7

Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.

Mirchandani D, Roses DF, Inghirami G, Zeleniuch-Jacquotte A, Cangiarella J, Guth A, Safyan RA, Formenti SC, Pagano M, Muggia F. Mirchandani D, et al. Among authors: roses df. Anticancer Res. 2011 Dec;31(12):4401-5. Anticancer Res. 2011. PMID: 22199306 Free PMC article.

8

Lobular carcinoma of the male breast.

Michaels BM, Nunn CR, Roses DF. Michaels BM, et al. Among authors: roses df. Surgery. 1994 Mar;115(3):402-5. Surgery. 1994. PMID: 8128366 Review.

9

Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection.

Eliasen CA, Opitz LM, Vamvakas EC, Espiritu EC, Marsh ER, Roses DF, Harris MN, Feiner HD. Eliasen CA, et al. Among authors: roses df. Mod Pathol. 1991 Mar;4(2):196-200. Mod Pathol. 1991. PMID: 2047382

10

Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed.

Cooper BT, Formenti-Ujlaki GF, Li X, Shin SM, Fenton-Kerimian M, Guth A, Roses DF, Hitchen CJ, Rosenstein BS, Dewyngaert JK, Goldberg JD, Formenti SC. Cooper BT, et al. Among authors: roses df. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):571-8. doi: 10.1016/j.ijrobp.2015.12.373. Epub 2015 Dec 29. Int J Radiat Oncol Biol Phys. 2016. PMID: 27131077 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page